Skip to content
Relaxo Footwears logo

Relaxo Footwears

RELAXO NSE
₹278.75 +2.80 (+1.01%)
Market Cap
₹6,939 Cr
P/E
37.27
View as Markdown
MCP
Close 20 Nov 2026 ₹278.75 1Y −124.15 −30.8%
Start ₹402.90

Key Fundamentals

MicrocapConsumer DurablesConsumer Discretionary

Price-based figures as of · EPS basis: Standalone · TTM

ROCE
11.20%
Debt to Equity
0.13
EPS (TTM)
₹7.48
Book Value
₹92.43
Market Cap
₹6,939 Cr
P/E (TTM)
37.27
P/B
3.02
ROE
8.33%
Dividend Yield
1.27%
EBITDA
₹420 Cr
52W High
₹454.70
52W Low
₹236.50
Day Range
₹271.40 – ₹279.80
Volume
1,57,322

Peer Comparison

Consumer Discretionary › Consumer Durables › Footwear

Relaxo Footwears peer comparison
833.6054.8122,72510.870.73%22.10%20.10%3,035420
634.5054.238,1556.574.01%10.60%12.70%3,613150
Relaxo Footwears (this company)
278.7537.276,9393.021.31%8.33%11.20%2,826187
192.9737.255,8996.450.77%18.00%21.20%1,882158
103.8522.675,7415.821.93%26.60%24.50%2,418254
267.8518.206201.180.72%4.70%6.97%26634
243.1451.844141.761.17%4.82%7.91%7538
Median 7 companies267.8537.275,8995.821.17%10.60%12.70%2,418158

Comparable companies in the same industry. Market cap, P/E and P/B use the latest price; other metrics are as reported in filings. A dash means the figure is not published for that company.

Tapetide Score

Data-driven rating, 0–100, as of . How it works →

Overall score

51 Average

Data confidence 100/100

Category scores

Quality
57
Good
Returns, margins, earnings quality 22% weight
Valuation
62
Good
Cheap vs sector & own history 24% weight
Growth
29
Poor
Sales & profit trajectory 9% weight
Financial Health
77
Strong
Solvency, leverage, coverage 9% weight
Momentum
20
Poor
Trend strength, vol-adjusted 12% weight
Ownership
47
Average
FII/DII/promoter flows 24% weight

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

Strengths

1
  • Company has been maintaining a healthy dividend payout of 43.2%

Weaknesses

3
  • Stock is trading at 3.02 times its book value
  • The company has delivered a poor sales growth of 2.75% over past five years.
  • Company has a low return on equity of 8.97% over last 3 years.

Technical Indicators

Technical signals: verdict and indicator counts
GroupSignalBearishNeutralBullish
OverallStrong Bearish1261
OscillatorsBearish261
Moving AveragesStrong Bearish1000

Key readings

RSI (14)
44.04
Neutral
MACD (12,26,9)
−4.43
Bearish
SMA (50)
292.07
Bearish
SMA (200)
331.60
Bearish

As of

Analyst Rating

Based on 8 analysts
BUY50%

4 of 8 analysts rate Buy, 3 Hold, 1 Sell.

As of

BUY
4
50%
HOLD
3
38%
SELL
1
13%

Growth Rate

From the financial statements below. 10Y, 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Sep 2026 against Sep 2025.

Revenue

Revenue growth by window
10Y+4.94%
5Y+2.75%
3Y−0.98%
1Y−3.15%
TTM+6.84%

Net profit

Net profit growth by window
10Y+4.08%
5Y−9.32%
3Y+5.14%
1Y+5.29%
TTM+7.47%

Operating cash flow

Operating cash flow growth by window
10Y+8.15%
5Y−7.47%
3Y−4.54%
1Y−14.29%
TTM—

TTM: Reported once a year, so there is no trailing-twelve-month figure.

Operating margin· change in pp

Operating margin growth by window
10Y−0.50 pp
5Y−7.16 pp
3Y+1.70 pp
1Y+0.15 pp
TTM−0.52 pp

Revenue by year

Revenue by year, ₹ crore
Mar 2017₹1,631 Cr
Mar 2018₹1,941 Cr
Mar 2019₹2,292 Cr
Mar 2020₹2,410 Cr
Mar 2021₹2,359 Cr
Mar 2022₹2,653 Cr
Mar 2023₹2,783 Cr
Mar 2024₹2,914 Cr
Mar 2025₹2,790 Cr
Mar 2026₹2,702 Cr

Net profit by year

Net profit by year, ₹ crore
Mar 2017₹120 Cr
Mar 2018₹161 Cr
Mar 2019₹175 Cr
Mar 2020₹226 Cr
Mar 2021₹292 Cr
Mar 2022₹233 Cr
Mar 2023₹154 Cr
Mar 2024₹200 Cr
Mar 2025₹170 Cr
Mar 2026₹179 Cr

Analyst Forecasts

Forecast For
Dec 26 consensus · EBITDA
₹74.40 Cr −23.8% vs Sep 26
Reported High Mean Low

AI Analysis — Bull vs Bear

Generated 31 Jul 2026
AI opinion · based on fundamentals
Risk high

Relaxo Footwears Ltd trades at a market cap of ₹10,066 Cr with a PE of 56.7x and ROE of approximately 8-9%, reflecting premium valuation against a backdrop of muted growth. Sales have compounded at just 3% over five years while the stock has declined 19% over the same period, though the company maintains a 43.2% dividend payout ratio.

Bull Case 7
  • Healthy dividend payout ratio of 43.2% indicates shareholder-friendly capital allocation and management confidence in cash flows
  • 10-year sales CAGR of 5% and 10-year profit CAGR of 4% demonstrate long-term business resilience through multiple cycles
  • 10-year ROE average of 13% suggests the business has historically generated reasonable returns on equity over a full cycle
  • TTM profit growth of 5% shows nascent margin recovery after a difficult period of -9% five-year profit CAGR
  • Dividend yield of 0.74% provides some income cushion relative to many consumer goods peers trading at similar multiples with lower yields
  • Stock decline of 24% over 3 years and 19% over 5 years means valuation has partially corrected from prior peaks, reducing some froth
  • Debt-to-equity is not flagged as a concern in known risks, suggesting the balance sheet remains relatively unleveraged for a footwear manufacturer
Bear Case 8
  • PE of 56.7x is extremely elevated for a company delivering only 5% TTM profit growth and negative 3% TTM sales growth
  • Price-to-book of 4.61x is high given last-year ROE of just 8%, implying the market pays a steep premium for subpar return generation
  • Five-year sales CAGR of only 2.75-3% indicates structural revenue growth challenges in a competitive mass-market footwear segment
  • ROE has deteriorated from a 10-year average of 13% to just 8% in the last year, signaling declining capital efficiency
  • Five-year profit CAGR of -9% reflects sustained earnings compression despite the company being in a supposedly defensive consumer sector
  • Stock has delivered negative returns across 1-year (-10%), 3-year (-24%), and 5-year (-19%) horizons, with only 5% CAGR over 10 years
  • TTM sales growth of -3% indicates the top-line is actively contracting, not merely growing slowly
  • Three-year ROE of 9% and declining trajectory suggests the premium valuation multiple is increasingly difficult to justify on fundamentals

This is AI-generated analysis, not financial advice. Do your own due diligence.

AI News Digest

112d ago

TL;DR: Limited recent news flow for Relaxo Footwears. The only development is a modest ₹25.67 crore block trade on Jul 17, which reflects institutional activity rather than any fundamental change. With no material headwinds or positive catalysts in the news cycle, the near-term outlook hinges on upcoming quarterly results and demand recovery trends in the consumer footwear segment.

Neutral 1
  • ₹25.67 Cr NSE block trade Jul 17

    A block trade of ~5.84 lakh shares executed at ₹439.95/share on NSE, totalling ₹25.67 crore. Likely an institutional rebalancing with no directional signal.

Quarterly Results

₹ Cr
RELAXO quarterly results, ₹ crore
Particulars Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Sales
715
713
747
748
679
667
695
654
629
668
751
705
702
Expenses
624
626
627
649
592
584
583
555
547
599
627
597
616
Operating Profit
92
87
120
99
88
83
112
99
81
69
124
108
85
OPM %
13%
12%
16%
13%
13%
12%
16%
15%
13%
10%
17%
15%
12%
Other Income
11
6
5
5
7
7
8
11
12
11
12
13
12.48
Interest
5
5
5
5
5
5
5
5
5
5
6
6
6.18
Depreciation
37
38
38
39
40
40
39
40
39
39
39
40
41.41
PBT
60
51
82
60
50
45
75
66
49
36
91
75
50.15
Tax %
27%
24%
25%
26%
26%
26%
25%
26%
26%
26%
25%
27%
26%
Net Profit
44
39
61
44
37
33
56
49
36
27
68
55
36.95
EPS (₹)
1.78
1.55
2.47
1.78
1.48
1.33
2.26
1.96
1.45
1.07
2.72
2.21
1.48
YoY Sales growth
7
5
−2
1
−5
−6
−7
−13
−7
0
8
8
12

Profit & Loss

₹ Cr
RELAXO profit and loss, annual, ₹ crore
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
1,441
1,668
1,631
1,941
2,292
2,410
2,359
2,653
2,783
2,914
2,790
2,702
2,826
Expenses
1,240
1,427
1,400
1,639
1,964
1,998
1,861
2,235
2,442
2,505
2,405
2,326
2,439
Operating Profit
201
241
231
302
328
413
498
418
341
409
385
377
387
OPM %
14%
14%
14%
16%
14%
17%
21%
16%
12%
14%
14%
14%
14%
Other Income
0
7
14
4
12
8
22
23
16
29
27
46
48
Interest
18
23
15
9
9
19
19
17
22
21
24
24
23
Depreciation
40
47
51
54
62
109
110
114
125
147
158
157
160
PBT
143
178
178
244
268
292
391
311
210
269
230
241
252
Tax %
28%
32%
33%
34%
35%
22%
25%
25%
26%
26%
26%
26%
—
Net Profit
103
120
120
161
175
226
292
233
154
200
170
179
186
EPS (₹)
4.29
5.01
4.99
6.69
7.07
9.11
11.74
9.35
6.21
8.05
6.84
7.20
7.48
Div. Payout %
6%
6%
10%
11%
13%
14%
21%
27%
40%
37%
44%
49%
—
Sales growth
22
16
−2
19
18
5
−2
12
5
5
−4
−3
7

Balance Sheet

₹ Cr
RELAXO balance sheet, annual, ₹ crore
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
6
12
12
12
12
25
25
25
25
25
25
25
25
Reserves
362
468
594
749
1,093
1,248
1,548
1,735
1,830
1,976
2,073
2,181
2,276
Borrowings
239
236
178
153
112
139
144
174
164
205
213
233
298
Other Liabilities
234
281
286
335
394
430
459
448
476
508
452
510
518
Total Liabilities
841
997
1,070
1,250
1,611
1,841
2,176
2,383
2,495
2,714
2,762
2,949
3,116
Fixed Assets
472
531
541
525
848
981
938
987
1,150
1,371
1,344
1,365
1,379
CWIP
2
28
62
138
11
46
118
149
89
33
54
97
114
Investments
0
0
1
1
0
0
338
194
225
108
343
436
328
Other Assets
367
438
466
587
752
814
782
1,052
1,030
1,202
1,021
1,051
1,295
Total Assets
841
997
1,070
1,250
1,611
1,841
2,176
2,383
2,495
2,714
2,762
2,949
3,116

Cash Flow

₹ Cr
RELAXO cash flow, annual, ₹ crore
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
107
159
180
154
123
319
513
56
400
235
406
348
Investing
−130
−130
−89
−108
−56
−116
−453
15
−258
−99
−262
−206
Financing
21
−31
−89
−46
−68
−203
−56
−70
−138
−106
−162
−146
Net Cash Flow
−1
−2
1
0
−1
1
4
1
3
30
−18
−5
Free Cash Flow
−23
25
90
46
32
203
391
−82
216
−11
291
213
CFO/EBITDA
72
89
103
78
64
97
121
33
134
74
120
110

Ratios

RELAXO financial ratios, annual
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
21
24
28
33
35
26
28
34
35
45
41
40
Inventory Days
163
147
146
130
130
157
154
202
154
179
177
184
Days Payable
61
63
63
72
58
65
81
67
69
76
63
87
Cash Conversion Cycle
123
108
110
90
107
119
101
170
121
148
155
138
Working Capital Days
14
12
19
27
42
57
44
75
59
68
62
63
ROCE %
30%
30%
26%
30%
26%
24%
26%
18%
12%
14%
11%
11%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Relaxo Footwears insights

65 extracted metrics across FY11–FY27.

Shareholding Pattern

As of Sep 2026

  • Promoters 71.27%
  • DIIs 9.58%
  • Others 9.56%
  • Public 6.63%
  • FIIs 2.97%

No promoter shares pledged as of Sep 2026

Change since Jun 2026

Not shown for some quarters: Others. Not available separately for this quarter: the shareholding filing gives Public and Others as one figure, shown under Public, so Others is left blank rather than estimated.

Documents

Frequently Asked Questions about Relaxo Footwears

What does Relaxo Footwears Ltd do?
Incorporated in 1984, Relaxo Footwear Ltd. is the largest footwear manufacturer in India.
Where is Relaxo Footwears Ltd (RELAXO) listed?
Relaxo Footwears Ltd trades as RELAXO on the NSE and under code 530517 on the BSE.
Which sector does Relaxo Footwears Ltd belong to?
Relaxo Footwears Ltd is classified under the Consumer Discretionary sector, in the Consumer Durables industry.
What is the market capitalisation of Relaxo Footwears Ltd?
Relaxo Footwears Ltd has a market capitalisation of ₹6,939 Cr as of 20 Nov 2026, which places it in the Microcap band.
What is the PE ratio of Relaxo Footwears Ltd?
Relaxo Footwears Ltd trades at a PE ratio of 37.27 as of 20 Nov 2026, on earnings per share of ₹7.48, against a book value of ₹92.43 per share.
What is the 52-week high and low of Relaxo Footwears Ltd?
Over the last 52 weeks Relaxo Footwears Ltd has traded between ₹236.5 and ₹454.7 as of 20 Nov 2026.
Does Relaxo Footwears Ltd pay dividends?
Relaxo Footwears Ltd has a dividend yield of 1.27%.
What is the Return on Equity (ROE) of Relaxo Footwears Ltd?
Relaxo Footwears Ltd reported a return on equity of 8.33%. Its debt-to-equity ratio is 0.13.

Company Information

Incorporated in 1984, Relaxo Footwear Ltd. is the largest footwear manufacturer in India.

CEO Mr. Ramesh Kumar Dua
Employees 7,355
Listed 17 Jun 2011
Face Value ₹1
Shares Outstanding 24,89,38,586

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/RELAXO.md for Relaxo Footwears Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More